FDA Adverse Event Other Summary report: N

INRATIO

MDR report key: 1835699 · Received September 9, 2010

Report

Report Number
2027969-2010-01398
Event Type
Other
Date Received
September 9, 2010
Date of Event
August 18, 2010
Report Date
September 9, 2010
Manufacturer
ALERE SAN DIEGO, INC.
Product Code
GJS
PMA / PMN Number
K021923
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CT, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION PENDING.

Description of Event or Problem · 1

"CALLER ALLEGED DISCREPANT RESULTS COMPARED WITH THE LAB. RESULTS AS FOLLOWS:" DATE: (B)(6) 2010, INRATIO: 1.8. DATE: (B)(6) 2010, INRATIO: >7.5, INRATIO2: >7.5. DATE: (B)(6) 2010, LAB: 7.3. REPEAT TESTING ON INRATIO2. ON (B)(6) 2010 TESTING USED STRIP LOT #234586. ON (B)(6) 2010 TESTING USED STRIP LOT #232886. PT WAS ADMITTED TO THIS FACILITY (B)(6); ON COUMADIN 5MG, ASPIRIN 325 MG, AND LOVENOX SUBQ 60 MG BID. ON MONDAY (B)(6) INR RESULTS USING STRIP LOT# 234586 WAS 1.8, DOSE WAS INCREASED TO COUMADIN 6MG.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 INRATIO PROTHROMBIN TIME TEST GJS ALERE SAN DIEGO, INC. 100139 232886

Patients

Seq Age Sex Outcome Treatment
1 Other